| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Sa | Compass Pathfinder Limited: Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments | 650 | Business Wire | Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical... ► Artikel lesen | |
| 08:54 | Bioxyne und Newron: Zwei Small Caps vor entscheidenden Weichenstellungen | Small- & Micro Cap Investment | |||
| Sa | New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings, Neonc Technologies Holdings, Medicus Pharma, YY Group Holding, and Vivos Therapeutics | 448 | ACCESS Newswire | The show also broadcasts as sponsored programming additionally across MENA and Latin America as "Nuevo En La Calle," reaching millions of households worldwide weekly, with expanded digital distribution... ► Artikel lesen | |
| 06:30 | Sanofi's Nuvaxovid Shows Superior Tolerability Over Moderna's MNEXSPIKE In COMPARE Study | 403 | AFX News | PARIS (dpa-AFX) - Sanofi's (SNY, SNYNF,SAN.PA) protein-based COVID-19 vaccine, Nuvaxovid (NVX-CoV2705), demonstrated a significantly better tolerability profile compared to Moderna's latest... ► Artikel lesen | |
| 11:21 | EQS-Media: HYTN setzt auf High-End-GMP: "HARd-Rollout" - mehr Leistung, mehr Qualität, mehr Marktpotenzial? | 346 | EQS Group (DE) | EQS-Media / 19.04.2026 / 11:15 CET/CEST
HYTN Innovations Inc. (ISIN: CA40443L1040 | WKN: A3DEUD), HYTN oder das Unternehmen, ein pharmazeutischer Hersteller, der sich auf Produkte mit psychoaktiven... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
|---|---|---|---|---|---|---|
| PERRIGO | 10,020 | 0,98 | +9,78 % | 0,29 | 02.03.2026 | |
| SANOFI | 81,90 | 3,92 | +4,79 % | 4,12 | 05.05.2026 | |
| NOVO NORDISK | 34,440 | 1,57 | +4,56 % | 7,95 | 27.03.2026 | |
| SINOPHARM | 2,239 | 0,08 | +3,57 % | 0,79 | 23.06.2026 | |
| CHUGAI PHARMACEUTICAL | 45,390 | 1,45 | +3,19 % | 66,00 | 29.06.2026 | |
| NOVARTIS | 129,50 | 4,11 | +3,17 % | 3,70 | 10.03.2026 | |
| GSK | 24,610 | 0,76 | +3,09 % | 0,18 | 19.02.2026 | |
| CSPC PHARMA | 0,973 | 0,03 | +3,08 % | 0,15 | 24.06.2026 | |
| ROCHE HOLDING | 359,80 | 10,85 | +3,02 % | 9,80 | 12.03.2026 | |
| KYOWA KIRIN | 13,100 | 0,33 | +2,52 % | 35,00 | 29.06.2026 |